Print

StemPar Sciences Secures Initial Funding For Its Novel Cancer Metabolism Drugs  
1/2/2013 9:24:54 AM

San Francisco, CA, Jan. 2, 2013 (GLOBE NEWSWIRE) -- Privately held StemPar Sciences, Inc. today announced an initial investment from Troika Venture Capital, a multi-profile international venture capital firm. In addition, Troika has committed to participate in future StemPar financings.
//-->